Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides
US8481055B2 · kind B2 · utility
3Cited by
19References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2010 |
| Grant date | Jul 9, 2013 |
| Priority date | — |
| Expiry date | Apr 16, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to a method of preventing or treating an infection caused by a bioterrorism agent, specifically to a method of increasing an immune response to a bioterrorism agent using an oligodeoxynucleotide including a CpG motif, and a method of enhancing the immunogenicity of a vaccine against a bioterrorism agent using an oligodeoxynucleotide including a CpG motif.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.